Anthraquinone derivative preservatives as natural alternatives to isothiazolinones in all-purpose cleaners

Overview

This research initiative focuses on developing anthraquinone derivatives as natural-based antimicrobial preservatives to replace isothiazolinones in all-purpose cleaners (APCs). The work builds on the discovery that certain 1,8-dihydroxyanthraquinones from botanical sources strongly inhibit pathogenic bacteria such as Staphylococcus aureus, Bacillus cereus, and Bacillus subtilis. By designing novel anthraquinone structures and formulating them as nanoemulsions, the project aims to produce highly active antimicrobial ingredients suitable for incorporation into cleaning product formulations. The solution addresses growing concerns about isothiazolinone preservatives while leveraging abundant botanical raw materials with naturally high anthraquinone content.

Technical specifications

Research approach and key features:

• Extraction and purification of 2–3 botanical sources to yield 5–10 anthraquinone compounds with strong, broad-spectrum antimicrobial activity
• Application of Quantitative Structure-Activity Relationship (QSAR) analysis and molecular modeling, including molecular dynamics simulation (MDS) and molecular docking, to design optimized anthraquinone structures
• Synthesis of the most promising derivative structures to maximize antimicrobial potency
• Formulation of nanoemulsions to enhance the antimicrobial efficacy of active ingredients
• Standard bioassay testing against molds, yeasts, and bacteria that commonly contaminate APCs
• Statistical analysis of inhibitory rate, minimum inhibitory concentration (MIC), IC50, and log reductions
• Pilot-scale production of raw materials and incorporation of active formulations into APC products

Technology readiness level

The research is currently at an early-to-mid stage of development. Initial discovery work has confirmed antimicrobial activity of select 1,8-dihydroxyanthraquinones against key bacterial pathogens. Future validation will progress through extraction and purification at pilot scale, computational design and synthesis of optimized derivatives, nanoemulsion formulation development, comprehensive antimicrobial efficacy testing, and final incorporation into APC formulations. The project is positioned to advance from laboratory validation toward prototype formulation testing.